Clinical Trials Browser

Phase 2 × Withdrawn × GRN163L peptide × Clear all

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral